Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I clinical trial to evaluate the safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 DNA adjuvant, boosted with homologuous plasmids in healthy, HIV-1-uninfected adult participants
Description
HVTN 060 is a Phase I clinical trial to evaluate the safety and immunogenicity of HIV-1 gag DNA vaccine with or without IL-12 DNA adjuvant.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.